Clinical Trial Update: TRANSfusion in Patients With Onco-hematological Malignancies ResusciTated From Septic Shock [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating transfusion in patients with hematologic malignancies resuscitated from septic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Hematologic Malignancy
• Septic Shock

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Septic Shock, Anemia | Phase 3 | Status: COMPLETED